FORM 8-K
Table of Contents

 
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
January 25, 2007
Date of Report (Date of earliest event reported)
APPLERA CORPORATION
(Exact name of registrant as specified in its charter)
         
Delaware   001-04389   06-1534213
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)
301 Merritt 7
Norwalk, Connecticut 06851

(Address of principal executive offices, including zip code)
(203) 840-2000
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


TABLE OF CONTENTS

Item 2.02. Results of Operations and Financial Condition
Item 9.01. Financial Statements and Exhibits
SIGNATURES
EXHIBIT INDEX
EX-99.1: PRESS RELEASE
EX-99.2: PRESS RELEASE


Table of Contents

Item 2.02. Results of Operations and Financial Condition.
     (a) On January 25, 2007, Applera Corporation (“Applera”) announced financial results for Applera and its business units for the second quarter of its 2007 fiscal year. Attached hereto as Exhibit 99.1 and incorporated by reference herein is the text of a press release issued on January 25, 2007, with respect to financial results for the second quarter of fiscal year 2007 of Applera and Applera’s Applied Biosystems Group, and attached hereto as Exhibit 99.2 and incorporated by reference herein is the text of a press release issued on January 25, 2007, with respect to financial results for the second quarter of fiscal year 2007 of Applera and Applera’s Celera Group.
Item 9.01. Financial Statements and Exhibits.
     (d) Exhibits.
     The following exhibits are filed with this Report:
     
Exhibit No.   Description
 
99.1
  Press Release issued January 25, 2007, with respect to financial results for Applera and Applera’s Applied Biosystems Group.
 
   
99.2
  Press Release issued January 25, 2007, with respect to financial results for Applera and Applera’s Celera Group.

 


Table of Contents

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  APPLERA CORPORATION
 
 
  By:   /s/ Dennis L. Winger    
    Dennis L. Winger   
    Senior Vice President and
Chief Financial Officer 
 
 
Dated: January 25, 2007

 


Table of Contents

EXHIBIT INDEX
     
Exhibit No.   Description
 
   
99.1
  Press Release issued January 25, 2007, with respect to financial results for Applera and Applera’s Applied Biosystems Group.
 
   
99.2
  Press Release issued January 25, 2007, with respect to financial results for Applera and Applera’s Celera Group.